Jpmorgan Chase & CO Stryker Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Stryker Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,617,277 shares of SYK stock, worth $5.09 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares

12,617,277

Previous 10,809,200 16.73%

Holding current value

$5.09 Billion

Previous $3.89 Billion 20.68%

% of portfolio

0.37%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$355.18 - $399.9 $642 Million - $723 Million	1,808,077 Added 16.73%	12,617,277 $4.7 Billion
Q4 2024 Feb 12, 2025	SELL	$345.14 - $392.15 $3.91 Million - $4.44 Million	-11,328 Reduced 0.1%	10,809,200 $3.89 Billion
Q3 2024 Dec 26, 2024	SELL	$315.94 - $371.96 $126 Million - $149 Million	-399,699 Reduced 3.56%	10,820,528 $3.91 Billion
Q3 2024 Nov 08, 2024	SELL	$315.94 - $371.96 $126 Million - $149 Million	-399,699 Reduced 3.56%	10,820,528 $3.91 Billion
Q2 2024 Dec 26, 2024	BUY	$324.3 - $354.67 $130 Million - $142 Million	399,699 Added 3.69%	11,220,227 $3.82 Billion
Q2 2024 Aug 12, 2024	BUY	$324.3 - $354.67 $833 Million - $911 Million	2,568,824 Added 29.69%	11,220,227 $3.82 Billion
Q1 2024 Dec 26, 2024	SELL	$293.94 - $358.71 $638 Million - $778 Million	-2,169,125 Reduced 20.05%	8,651,403 $3.1 Billion
Q1 2024 May 10, 2024	BUY	$293.94 - $358.71 $239 Million - $292 Million	813,311 Added 10.38%	8,651,403 $3.1 Billion
Q4 2023 Dec 26, 2024	SELL	$253.85 - $299.46 $757 Million - $893 Million	-2,982,436 Reduced 27.56%	7,838,092 $2.35 Billion
Q4 2023 Feb 12, 2024	BUY	$253.85 - $299.46 $1.12 Billion - $1.33 Billion	4,427,566 Added 129.82%	7,838,092 $2.35 Billion
Q3 2023 Nov 14, 2023	BUY	$266.54 - $302.43 $264 Million - $300 Million	990,979 Added 40.96%	3,410,526 $932 Million
Q2 2023 Aug 11, 2023	BUY	$271.49 - $305.09 $109 Million - $122 Million	400,673 Added 19.85%	2,419,547 $738 Million
Q1 2023 May 18, 2023	BUY	$246.13 - $285.47 $39.1 Million - $45.3 Million	158,670 Added 8.53%	2,018,874 $576 Million
Q1 2023 May 11, 2023	BUY	$246.13 - $285.47 $135 Million - $156 Million	548,169 Added 41.78%	1,860,204 $531 Million
Q4 2022 Feb 13, 2023	BUY	$205.51 - $253.93 $105 Million - $129 Million	509,000 Added 63.38%	1,312,035 $321 Million
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $20.5 Million - $25.2 Million	108,526 Added 15.63%	803,035 $163 Million
Q2 2022 Aug 11, 2022	SELL	$194.09 - $276.37 $16.5 Million - $23.5 Million	-85,158 Reduced 10.92%	694,509 $138 Million
Q1 2022 May 11, 2022	BUY	$245.33 - $277.77 $9.63 Million - $10.9 Million	39,256 Added 5.3%	779,667 $208 Million
Q4 2021 Feb 10, 2022	BUY	$236.63 - $276.44 $47.3 Million - $55.2 Million	199,704 Added 36.93%	740,411 $198 Million
Q3 2021 Nov 12, 2021	BUY	$248.9 - $280.09 $135 Million - $151 Million	540,707 New	540,707 $143 Million

Others Institutions Holding SYK

# of Institutions

2,504

Shares Held

290M

Call Options Held

1.39M

Put Options Held

910K

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $153B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Stryker Corp Transaction History